Abstract:Abstract Background MicroRNA-200c (miR-200c) is one of the short noncoding RNAs that play crucial roles in tumorigenesis and tumor progression. It also acts as considerable modulator in the process of epithelial-to-mesenchymal transition (EMT), a cell development regulating process that affects tumor development and metastasis. However, the role of miR-200c in bladder cancer cells and its mechanism has not been well studied. The purpose of this study was to determine the potential role of miR-200c in regulating EMT and how it contributed to bladder cancer cells in invasion, migration and proliferation. Methods Real-time reverse transcription-PCR was used to identify and validate the differential expression of MiR-200c involved in EMT in 4 bladder cancer cell lines and clinical specimens. A list of potential miR-200 direct targets was identified through the TargetScan database. The precursor of miR-200c was over-expressed in UMUC-3 and T24 cells using a lentivirus construct, respectively. Protein expression and signaling pathway modulation were validated through Western blot analysis and confocal microscopy, whereas BMI-1 and E2F3, direct target of miR-200c, were validated by using the wild-type and mutant 3’-untranslated region BMI-1/E2F3 luciferase reporters. Results We demonstrate that MiR-200c is down-regulated in bladder cancer specimens compared with adjacent ones in the same patient. Luciferase assays showed that the direct down-regulation of BMI-1 and E2F3 were miR-200c-dependent because mutations in the two putative miR-200c-binding sites have rescued the inhibitory effect. Over-expression of miR-200c in bladder cancer cells resulted in significantly decreased the capacities of cell invasion, migration and proliferation. miR-200c over-expression resulted in conspicuous down-regulation of BMI-1and E2F3 expression and in a concomitant increase in E-cadherin levels. Conclusions miR-200c appears to control the EMT process through BMI-1 in bladder cancer cells, and it inhibits their proliferation through down-regulating E2F3. The targets of miR-200c include BMI-1 and E2F3, which are a novel regulator of EMT and a regulator of proliferation, respectively.

miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.

MicroRNA-26a Acts As a Tumor Suppressor Inhibiting Gallbladder Cancer Cell Proliferation by Directly Targeting HMGA2.

MiRNA‐516a Promotes Bladder Cancer Metastasis by Inhibiting MMP9 Protein Degradation Via the AKT/FOXO3A/SMURF1 Axis

Mir-26A Suppresses Gastric Cancer Cell Invasion by Targeting MMP16

MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2

Downregulation of Microrna-532-5p Promotes the Proliferation and Invasion of Bladder Cancer Cells Through Promotion of HMGB3/Wnt/β-catenin Signaling

The miR－26a inhibits proliferation and migration ability of MDA －MB －231 cells via regulation of E2F7 and Myc

Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p

Mirna‑26a‑5p and Mir‑26b‑5p Inhibit the Proliferation of Bladder Cancer Cells by Regulating PDCD10

MiR-22 Suppresses Epithelial–mesenchymal Transition in Bladder Cancer by Inhibiting Snail and MAPK1/Slug/vimentin Feedback Loop

MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA Through the PIK3C2α/Akt/HIF-1α Pathway in Hepatocellular Carcinoma.

MicroRNA-26a Regulates Tumorigenic Properties of EZH2 in Human Lung Carcinoma Cells.

Microrna-26a Suppresses Angiogenesis in Human Hepatocellular Carcinoma by Targeting Hepatocyte Growth Factor-Cmet Pathway

miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3

MiR-26a-5p regulates proliferation, apoptosis, migration and invasion via inhibiting hydroxysteroid dehydrogenase like-2 in cervical cancer cell

MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin.

Pathologically Decreased Mir-26A Antagonizes Apoptosis and Facilitates Carcinogenesis by Targeting MTDH and EZH2 in Breast Cancer.

Mir-26A Promoted by Interferon-Alpha Inhibits Hepatocellular Carcinoma Proliferation and Migration by Blocking EZH2.

MicroRNA-26a: An Emerging Regulator of Renal Biology and Disease.

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.

miR-30e-5p suppresses cell proliferation and migration in bladder cancer through regulating metadherin.